España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Acumen Pharmaceuticals
ABOS
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.07
-0.08
-2.54%
At Close: -
$3.11
0.04
1.30%
After Hours: 7:36 PM EDT
15 minutes delayed
Get Report
Comment
Acumen Pharmaceuticals (ABOS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Acumen Pharmaceuticals (NASDAQ:ABOS) Stock
Acumen Pharmaceuticals Stock (NASDAQ: ABOS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Acumen Pharmaceuticals To Present Patient Exp...
Benzinga Newsdesk
Thursday, June 06, 2024
Halozyme's ENHANZE Product Gets New Patent Grant in EU
Zacks
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Acumen ...
Benzinga Newsdesk
Tuesday, May 14, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Acumen Pharmaceuticals Q1 2024 GAAP EPS $(0.2...
Benzinga Newsdesk
Wednesday, May 08, 2024
Acumen Pharmaceuticals Says First Patient Dos...
Benzinga Newsdesk
Thursday, April 18, 2024
Watching Eledon Pharmaceuticals, Acumen Pharm...
Benzinga Newsdesk
Tuesday, April 16, 2024
Acumen Pharmaceuticals Presents First Compreh...
Benzinga Newsdesk
Thursday, April 04, 2024
Acumen Pharmaceuticals Collaborates With Lonz...
Benzinga Newsdesk
Wednesday, March 27, 2024
HC Wainwright & Co. Maintains Buy on Acumen P...
Benzinga Newsdesk
Tuesday, March 26, 2024
Acumen Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Acumen Pharmaceuticals Q4 EPS $(0.29) Misses $(0.26) Estimate
Happy Mohamed
Acumen Pharmaceuticals FY23 EPS $(1.08) Down ...
Benzinga Newsdesk
Earnings Scheduled For March 26, 2024
Benzinga Insights
Monday, March 25, 2024
Acumen Pharmaceuticals's Earnings: A Preview
Benzinga Insights
Thursday, March 21, 2024
Acumen Pharmaceuticals To Present Deeper Insi...
Benzinga Newsdesk
Friday, March 08, 2024
Acumen Pharmaceuticals Presents Sabirnetug Fl...
Benzinga Newsdesk
Acumen Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Wednesday, February 21, 2024
Acumen Pharmaceuticals To Present Sabirnetug ...
Benzinga Newsdesk
Thursday, February 01, 2024
Acumen Pharmaceuticals Appointsf James Dohert...
Benzinga Newsdesk
Tuesday, December 12, 2023
Deutsche Bank Initiates Coverage On Acumen Ph...
Benzinga Newsdesk
Monday, November 13, 2023
Acumen Pharmaceuticals Secures $50.0M Credit ...
Benzinga Newsdesk
Acumen Pharmaceuticals Q3 EPS $(0.24) Vs $(0....
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Acumen Pharmaceuticals's Earnings Outlook
Benzinga Insights
Monday, November 06, 2023
Acumen Pharmaceuticals, Inc. And Halozyme Ent...
Benzinga Newsdesk
Friday, October 27, 2023
Acumen Pharmaceuticals Presents Late-Breaker ...
Benzinga Newsdesk
Wednesday, October 04, 2023
Acumen Pharmaceuticals To Present Deeper Insi...
Benzinga Newsdesk
Wednesday, September 06, 2023
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
David Willey
-
Sponsored
Wednesday, August 09, 2023
Credit Suisse Reiterates Outperform on Acumen...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Acumen ...
Benzinga Newsdesk
Tuesday, August 08, 2023
Acumen Pharmaceuticals Q2 EPS $(0.28) Beats $...
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Acumen Pharmaceuticals's Earnings: A Preview
Benzinga Insights
Wednesday, July 26, 2023
Director At This Health Care Company Buys $40.00M of Stock
Benzinga Insights
$40M Bet On Acumen Pharmaceuticals? Check Out These 3 Stocks Insiders Are Buying
Lisa Levin
Neuroinflammation A Key Indicator For Alzheimer's, But Current Treatments Show Little Success In Reducing Or Even Increase It — Could This Rising Company Have The Answer?
David Willey
-
Sponsored
Thursday, July 20, 2023
B of A Securities Reinstates Buy on Acumen Ph...
Benzinga Newsdesk
Wednesday, July 19, 2023
Acumen Pharmaceuticals Upsizes Its Previously...
Benzinga Newsdesk
Tuesday, July 18, 2023
Acumen Pharmaceuticals shares are trading low...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Masimo, Acumen Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
Monday, July 17, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Acumen Pharmaceuticals Commence Public Offeri...
Benzinga Newsdesk
Acumen Pharmaceuticals Plans To File A Preliminary Prospectus Supplement With The SEC For A Proposed Offering Of Common Stock, And As Of June 30, 2023, The Company Had Approximately $172.2M In Cash And Marketable Securities
Happy Mohamed
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Ford Motor Cuts Prices For F-150 Lightning Truck, Microsoft-Sony Sign Agreement for 'Call of Duty,' Alibaba Stock Slips on China's Q2 GDP Sentiment: Today's Top Stories
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch